EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Signature Gene Mutations in Colorectal Cancer: Potential Neoantigens for Cancer Vaccines

Jaegoo Yoon, Haeun Moon, Yuna Jeon, Soohyun Choe iD, Hyunho Yoon iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26104559 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Jaegoo Yoon und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Biological Sciences, The Catholic University of Korea, Bucheon 14662, Republic of Korea. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Cancer Vaccines, Mutation, Antigens, Neoplasm. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 162 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Catholic University of Korea, Ministry of Food and Drug Safety, Ministry of Food and Drug Safety in Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC), the third most common cancer worldwide, is one of the deadliest cancers. CRC is known as a cold tumor, characterized by a low immune response that makes it difficult for immune cells to infiltrate and exhibits strong resistance to immunotherapy with checkpoint inhibition. This restricted response is largely attributed to signature gene mutations including mismatch repair (MMR) genes, KRAS, BRAF, APC, and TP53, which are also the main oncogenes in CRC. Mutated signature genes continuously upregulate abnormal signaling pathways, leading to excessive proliferation, cancer progression, and metastasis. Furthermore, it reorganizes the tumor microenvironment (TME) by recruiting immunosuppressive cells. However, the mutation can produce neoantigens that can provoke an immune response, making it a potential target for immunotherapy. In particular, cancer vaccines that leverage the strong neoantigenic properties of these mutations are considered promising for overcoming immune resistance and eliciting anti-tumor responses. In this review, we will describe signature gene mutations in CRC and focus on cancer vaccines targeting these mutations as potential therapies for CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsCancer VaccinesMutationAntigens, NeoplasmHumansTumor MicroenvironmentImmunotherapyAnimals

Stichwörter der Autor:innen

cancer vaccinecold tumorcolorectal cancerneoantigensignature genestumor microenvironment

Substanzen

Cancer VaccinesAntigens, Neoplasm

Autor:innen und Institutionen

  • Department of Medical and Biological Sciences, The Catholic University of Korea, Bucheon 14662, Republic of Korea.
  • Department of Biotechnology, The Catholic University of Korea, Bucheon 14662, Republic of Korea.

ORCID-Profile: Soohyun Choe, Hyunho Yoon

Förderung

  • Catholic University of Korea
  • Ministry of Food and Drug Safety
  • Ministry of Food and Drug Safety in Korea

Zitieren

APA

Yoon, J., Moon, H., Jeon, Y., Choe, S., & Yoon, H. (2025). Signature Gene Mutations in Colorectal Cancer: Potential Neoantigens for Cancer Vaccines. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26104559

Vancouver

Yoon J, Moon H, Jeon Y, Choe S, Yoon H. Signature Gene Mutations in Colorectal Cancer: Potential Neoantigens for Cancer Vaccines. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26104559

BibTeX
@article{Yoon2025,
  author = {Yoon, Jaegoo and Moon, Haeun and Jeon, Yuna and Choe, Soohyun and Yoon, Hyunho},
  title = {Signature Gene Mutations in Colorectal Cancer: Potential Neoantigens for Cancer Vaccines},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26104559}
}
Kostenlos starten →